ARTICLE;
CHILD;
DRUG FORMULATION;
DRUG PREFERENCE;
DRUG RETENTION;
DRUG USE;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
REGRESSION ANALYSIS;
UNITED KINGDOM;
AGE FACTORS;
ANTI-RETROVIRAL AGENTS;
CHEMISTRY, PHARMACEUTICAL;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
LONDON;
MALE;
MEDICAL RECORDS SYSTEMS, COMPUTERIZED;
PHARMACEUTICAL SOLUTIONS;
REGRESSION ANALYSIS;
RETROSPECTIVE STUDIES;
REVERSE TRANSCRIPTASE INHIBITORS;
STAVUDINE;
TIME FACTORS;
Lack of appropriate formulations of medicines for children in the community
E Schirm H Tobi TW de Vries I Choonara LT De Jong-van den Berg 2003 Lack of appropriate formulations of medicines for children in the community Acta Paediatr 92 1486 9
Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase
PL Sharma V Nurpeisov B Hernandez-Santiago T Beltran RF Schinazi 2004 Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase Curr Top Med Chem 4 895 919
A pharmacoepidemiological study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy
10
ICK Wong GE Mawer JWAS Sander SD Lhatoo 2001 A pharmacoepidemiological study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy Epilepsia 42 10 1354 8
Long-term retention rates of lamotrigine, gabapentin and topiramate in chronic epilepsy
12
SD Lhatoo ICK Wong G Polizzi JWAS Sander 2000 Long-term retention rates of lamotrigine, gabapentin and topiramate in chronic epilepsy Epilepsia 41 12 1592 6
The long-term use of gabapentin, lamotrigine and vigabatrin in patients with chronic epilepsy
10
ICK Wong D Chadwick PBC Fenwick GE Mawer JWAS Sander 1999 The long-term use of gabapentin, lamotrigine and vigabatrin in patients with chronic epilepsy Epilepsia 40 10 1439 45
Teaching developmentally disabled children with chronic illness to swallow prescribed capsules
RL Babbitt JM Parrish PE Brierly MA Kohr 1991 Teaching developmentally disabled children with chronic illness to swallow prescribed capsules J Dev Behav Pediatr 12 229 35